EGFR kinase inhibitor 2 (compound A-7) is a potent EGFR inhibitor targeting the mutations EGFRL858R/T790M/C797S and EGFRDel19/T790M/C797S. This compound shows potential in addressing acquired resistance in the treatment of non-small cell lung cancer.
Formula:
C39H40N6O5
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted